122684-35-9 Usage
General Description
3-Thiocarbamoyl-pyrrolidine-1-carboxylic Acid Tert-Butyl Ester is a specialized chemical compound. Its selection as a tert-butyl ester suggests it is typically used in laboratory or industrial settings, often as a compound in a larger chemical reaction. The presence of pyrrolidine implies it may be involved in alkaloid synthesis, a common occurrence in pharmaceutical production. Its thiocarbamoyl portion points to it having sulfur properties, which means it might be used to create other sulfonyl-related compounds. As with all chemicals, it should be handled with care and adequate protection due to potential reactivity or toxicity. Specific data regarding this compound's direct applications is not widely available, indicating it is possibly used for very specialized purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 122684-35-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,2,6,8 and 4 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 122684-35:
(8*1)+(7*2)+(6*2)+(5*6)+(4*8)+(3*4)+(2*3)+(1*5)=119
119 % 10 = 9
So 122684-35-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H18N2O2S/c1-10(2,3)14-9(13)12-5-4-7(6-12)8(11)15/h7H,4-6H2,1-3H3,(H2,11,15)
122684-35-9Relevant articles and documents
NOVEL FERROPORTIN INHIBITORS
-
Page/Page column 231, (2017/05/10)
The invention relates to novel ferroportin inhibitors of the general formula (I) pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for the prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, such as particularly iron overload states such as in particular thalassemia and hemochromatosis.
FUSED THIAZOLE DERIVATIVES HAVING AFFINITY FOR THE HISTAMINE H3 RECEPTOR
-
Page/Page column 23, (2008/06/13)
The present invention relates to novel fused thiazole derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
